Entropy Neurodynamics Limited has released a press release.
Exopharm and AIRM Sign MSA
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Exopharm Gains US Patent for LEAP Technology
- Exopharm LEAP Technology - Further Step Towards US Patent
- Exopharm LEAP Technology - Second Commercial Collaboration
- FY2021 Appendix 4E and Annual Report
- Exopharm LEAP Exosome Technology Granted 1st National Patent
Later from Entropy Neurodynamics
- Response to ASX Query
- Appendix 4D and Half Year Report for period 31 December 2021
- Response to ASX Price Query
- Business Update
- EX1 to Receive over $2.7m in Prepaid R&D Tax Incentive Claim
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics